Business ❯ Biotechnology

Clinical Research

Drug Development Celcuity Inc. Pharmaceuticals Nanotechnology Pharmaceutical Companies Drug Approval Process Acquisitions Drug Efficacy Therapeutics Oncology

Atrogi Begins Dosing in 8-Week Human Study of GRK2-Biased β2 Agonist ATR-258

The investigator-led trial will probe how the next-generation modulator influences human skeletal muscle to guide development.

Gilead to Acquire Arcellx for Up to $7.8 Billion to Gain Full Control of CAR-T Anito-Cel

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

Protara Reports Strong Interim Phase 2 Results for TARA-002 in Pediatric Lymphatic Malformations

Rapport Seizure Drug Posts Strong Phase 2 Signal as Company Plans Phase 3

Cassava Sciences Halts Alzheimer’s Drug Trials Following Phase 3 Failure